Genomically Driven Precision Medicine to Improve Outcomes in Anaplastic Thyroid Cancer

Genomically Driven Precision Medicine to Improve Outcomes in Anaplastic Thyroid Cancer

Thyroid cancer is an endocrine malignancy with an incidence rate that has been increasing steadily over the past 30 years. While well-differentiated subtypes have a favorable prognosis when treated with surgical resection and radioiodine, undifferentiated subtypes, such as anaplastic thyroid cancer...

Full description

Bibliographic Details
Main Authors: Nicole Pinto, Morgan Black, Krupal Patel, John Yoo, Joe S. Mymryk, John W. Barrett, Anthony C. Nichols
Format: Article
Language:English
Published: Hindawi Limited 2014-01-01
Series:Journal of Oncology
Online Access:http://dx.doi.org/10.1155/2014/936285

Similar Items

Similar Items